180 participants
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-12
- Start Date:
- 2026-06-16
- Completion:
- 2027-06-30
Conditions
- Pancreatic Ductal Adenocarcinoma (PDAC)
- G12D Mutated KRAS
Interventions
- DRUG
No Results Yet